RAD51C-deficient cancer cells are highly sensitive to the PARP inhibitor olaparib (Q28287553)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | RAD51C-deficient cancer cells are highly sensitive to the PARP inhibitor olaparib |
scientific article |
Statements
RAD51C-deficient cancer cells are highly sensitive to the PARP inhibitor olaparib (English)
0 references
June 2013
0 references
12
0 references
865-77
0 references
6
0 references